David Lebwohl in

David Lebwohl

Login to view DISC.
Chief Medical Officer at Intellia Therapeutics, Inc.
📍 Madison, New Jersey, United States

Dr. David Lebwohl is the Chief Medical Officer at Intellia Therapeutics, leveraging his extensive background in oncology and novel therapeutics. A graduate of Harvard and Yale School of Medicine, he previously held senior roles at Novartis, where he led the development of the pioneering CAR-T cell therapy, Kymriah.

He has a significant track record of leading teams in the development of groundbreaking treatments, from his time at Semma Therapeutics (acquired by Vertex) to his current focus on CRISPR-based medicines at Intellia.

Read the full overview →
Experience
12 Years
Current Role
Chief Medical Officer
Job Level
Leadership
Location
Madison, New Jersey, United States
Personality Overview

How David shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics David cares about

CRISPR Therapeutics
As CMO of Intellia, he actively leads and discusses the clinical advancement of CRISPR-based treatments for genetic diseases like ATTR amyloidosis and Hereditary Angioedema (HAE).
Cell & Gene Therapy
He has deep expertise in this area, having led the global program for Kymriah (CTL019), one of the first approved CAR-T cell therapies, during his tenure at Novartis.
+5 more topics Login to view topics
Career

Work history

4-2020
Chief Medical Officer
Intellia Therapeutics, Inc.
11-2018 - 4-2020
Chief Medical Officer
Semma Therapeutics
9-2016 - 11-2018
Senior VP and Exec. Global Program Head, CART Global Program Team
Novartis
3-2015 - 8-2016
Senior VP and Exec. Global Program Head, CTL019, Cell and Gene Therapies Unit, Novartis
Novartis
5-2013 - 3-2015
Sr. VP and Global Head, Oncology Clinical Development
Novartis
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
1977 - 1981
Doctor of Medicine (MD)
Yale School of Medicine
AB
Harvard University
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Brendan Anderson
Brendan Anderson
Manager | Paid Media and Partnerships
Lithia Motors, Inc.
 Cristian Del Rio
Cristian Del Rio
Vice President, Chief Financial Officer
Zurich Insurance Company Ltd
DA
David Alain Wohl
Professor
The University of North Carolina Instituite of Global Health and Infectious Diseases
 Paul J. Bailo
Paul J. Bailo
Executive Instructor | Digital Transformation | AI | Management Consulting | Leadership
Caltech Center for Technology and Management Education (Caltech CTME)
Unlock the full playbookSee exactly how to sell to David. Free, 10 seconds.